STOCK TITAN

Sangamo Therapeutics Announces First Quarter 2021 Conference Call and Webcast

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Sangamo Therapeutics (Nasdaq: SGMO) has announced the release of its first quarter 2021 financial results, scheduled for May 4, 2021, after market close. Following this, the Company will host a conference call at 5:00 p.m. ET to discuss the financial performance and provide updates on its business activities. Participants can join the call via telephone or webcast, with dial-in numbers provided for domestic and international callers.

Positive
  • Scheduled financial results release demonstrates transparency and communication with investors.
  • The conference call allows stakeholders to gain insights into the Company's performance and strategy.
Negative
  • None.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its first quarter 2021 financial results after the market closes on Tuesday, May 4, 2021. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the Company will review its financial results and provide business updates.

The conference call dial-in numbers are (877) 377-7553 for domestic callers and (678) 894-3968 for international callers. The conference ID number for the call is 5714729. Participants may access the live webcast via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. A conference call replay will be available for one week following the conference call. The conference call replay numbers for domestic and international callers are (855) 859-2056 and (404) 537-3406, respectively. The conference ID number for the replay is 5714729.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.

FAQ

When will Sangamo Therapeutics release its first quarter 2021 financial results?

Sangamo Therapeutics will release its first quarter 2021 financial results on May 4, 2021, after market close.

What time is the Sangamo Therapeutics conference call regarding financial results?

The conference call will take place at 5:00 p.m. ET on May 4, 2021.

How can I participate in the Sangamo Therapeutics conference call?

You can participate in the conference call by dialing (877) 377-7553 for domestic callers or (678) 894-3968 for international callers.

Where can I find the webcast for the Sangamo Therapeutics conference call?

The live webcast can be accessed via a link on the Sangamo Therapeutics website under the Investors and Media section.

Sangamo Therapeutics, Inc.

NASDAQ:SGMO

SGMO Rankings

SGMO Latest News

SGMO Stock Data

457.98M
202.87M
2.38%
27.16%
9.11%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
RICHMOND